Strategic Acquisition Renaissance Lakewood has recently been acquired by LTS Lohmann Therapie-Systeme AG, which broadens its capabilities and market reach within the CDMO sector, presenting opportunities for clients seeking a partner with expanded technological and operational expertise.

Therapeutic Focus The company specializes in nasal sprays and sterile injectables, including advanced formulations like monoclonal antibodies and high-risk neuroblastoma treatments, indicating a strong position within niche, high-value therapeutic areas suitable for targeted collaborations.

Collaborative Projects Recent partnerships with biotech firms such as Tiziana Life Sciences and research institutions like St. Jude highlight Renaissance’s active engagement in innovative and life-changing therapies, creating potential for joint development and co-marketing opportunities.

Technology & Development Utilizing advanced manufacturing technologies including aseptic fill-finish and nasal spray development coupled with analytical and formulation expertise, Renaissance can support clients seeking high-quality, scalable production solutions for complex biologics and small molecules.

Revenue & Market Position With annual revenues estimated between 100M and 250M and an experienced workforce, Renaissance operates competitively among mid-tier pharmaceutical contract manufacturers, offering reliable endpoints for partnership and outsourcing opportunities in sensitive therapeutic areas.